down arrow

Hikal

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE475B01022
  • NSEID: HIKAL
  • BSEID: 524735
INR
419.00
35.95 (9.39%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.81 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Hikal Ltd stock-summary
stock-summary
Hikal Ltd
Small Cap
Pharmaceuticals & Drugs
Hikal Limited, incorporated on July 08th, 1988, has emerged as one of the preferred partners for global companies in segments such as pharmaceuticals, crop protection, animal health, biocides, and specialty chemicals. The Company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. Presently, it is operating in the crop protection and pharmaceuticals space.
Company Coordinates stock-summary
Company Details
717/718 Maker Chamber V, 7th Floor Nariman Point Mumbai Maharashtra : 400021
stock-summary
Tel: 91-022-3926 7100/62770477
stock-summary
secretarial@hikal.com/info@hikal.co
Registrar Details
Mondkar Computers Pvt Ltd , 21 Shakil Niwas , Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 24.66 Cr
Number of Shares
12.33 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
22-Jun-2018
12.33
24.66
41100250
2
Bonus
27-Feb-2015
8.22
16.44
65760400
2
Stock Split
27-Feb-2015
8.22
16.44
65760400
2
Stock Split
29-Sep-2008
1.64
16.44
1360000
10
Equity Alloted To FII
29-Sep-2008
1.64
16.44
1360000
10
Equity Alloted To FII
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 6 Schemes (2.92%)

FIIs

Held by 79 FIIs (6.06%)

Promoter with highest holding

Kalyani Investment Company Limited (31.36%)

Highest Public shareholder

Tata Mutual Fund - Tata Small Cap Fund (2.68%)

Individual Investors Holdings

16.64%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Baba Kalyani
Non-Exec & Non-Independent Dir
10.6 lacs
Jai Hiremath
Executive Chairman
5.09 cr
Sameer Hiremath
Managing Director
4.19 cr
Kannan Unni
Non-Exec. & Independent Dir.
18.6 lacs
Sugandha Hiremath
Non-Exec & Non-Independent Dir
16.6 lacs
Prakash V Mehta
Non-Exec. & Independent Dir.
19.6 lacs
Amit B Kalyani
Non-Exec & Non-Independent Dir
8.6 lacs
Ranjit Shahani
Non-Exec. & Independent Dir.
15.6 lacs
Shivani Bhasin Sachdeva
Non-Exec. & Independent Dir.
11.6 lacs
Rajasekhar Reddy
Company Sec. & Compli. Officer
0
Shrikrishna K. Adivarekar
Independent Director
10.6 lacs
Berjis Minoo Desai
Independent Director
0
V R Kaundinya
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Bulk Drugs
939.14
59.08%
Crop Protection Products
650.47
40.92%
 
59.08
Bulk Drugs
40.92
Bulk Drugs
40.92
Crop Protection Products
59.08
Crop Protection Products
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
448 Cr
(Quarterly Results - Dec 2024)
Net Profit:
17 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 5,166 Cr (Small Cap)

stock-summary
P/E

63.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.31%

stock-summary
Debt Equity

0.61

stock-summary
Return on Equity

6.10%

stock-summary
Price to Book

3.92